Leveraging the increased rates of pathologic complete response after neoadjuvant treatment in breast cancer to de‐escalate surgical treatments-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Leveraging the increased rates of pathologic complete response after neoadjuvant treatment in breast cancer to de‐escalate surgical treatments

Published:2020-10 Issue:1 Volume:123 Page:71-79
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J Surg Oncol

Author:

Esgueva Antonio¹^ORCID,Siso Christian²,Espinosa‐Bravo Martin²,Sobrido Carolina³,Miranda Ignacio⁴,Salazar Juan P.⁴,Rubio Isabel T.¹^ORCID

Affiliation:

1. Department of Breast Surgical Oncology Clinica Universidad de Navarra Universidad de Navarra Madrid Spain

2. Department of Breast Surgical Oncology Hospital Universitario Vall d'Hebron Universitat Autonoma de Barcelona Barcelona Spain

3. Breast Imaging Unit, Department of Radiology Clinica Universidad de Navarra Universidad de Navarra Madrid Spain

4. Breast Imaging Unit, Department of Radiology Hospital Universitario Vall d'Hebron Universitat Autonoma de Barcelona Barcelona Spain

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jso.26236

Reference38 articles.

1. Breast Conservation After Neoadjuvant Chemotherapy: The M.D. Anderson Cancer Center Experience

2. Breast Conservation After Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer

3. Long‐term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta‐analysis of individual patient data from ten randomized trials;Early Breast Cancer Tialists' Collaborative Group (EBCTCG);Lancet Oncol,2018

4. Perspectives on preoperative systemic treatment and breast conservative surgery: One step forward or two steps back?

5. Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer;Boughey JC;Ann Surg,2006

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: Is it necessary?;The Breast;2024-02

2. Contrast-enhanced breast imaging: Current status and future challenges;European Journal of Radiology;2024-02

3. Feasibility and safety of targeted axillary dissection guided by intraoperative ultrasound after neoadjuvant treatment;European Journal of Surgical Oncology;2023-10

4. Sentinel Node Biopsy in Patients With Breast Carcinoma Without Axillary Involvement at Diagnosis Receiving Primary Systemic Therapy;Clinical Breast Cancer;2023-08

5. The nodal positivity rate in breast pCR patients with initially, clinically node-negative breast cancer after neoadjuvant systemic therapy: A systematic review and meta-analysis;Frontiers in Oncology;2023-03-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3